The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis
NCT00012506
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
NIH
Sponsor class
Conditions
Uveitis
Arthritis, Juvenile Rheumatoid
Interventions
DRUG:
TNFR:Fc
Sponsor
National Eye Institute (NEI)